Myriocin (ISP-1)
StrongMechanism of Action
Research Notes
Myriocin was first isolated from Isaria sinclairii and demonstrated 10–100 times greater immunosuppressive potency than cyclosporine A with fewer nephrotoxic side effects. The derivative fingolimod received FDA approval in 2010 for relapsing-remitting multiple sclerosis (Gilenya). Myriocin content in wild and artificially cultivated I. cicadae varies significantly — some studies report levels below detection limits while others document measurable amounts, suggesting strain-dependent production. Recent research (2024) in age-related macular degeneration models demonstrated protective effects of myriocin through ceramide pathway modulation.
Found In 1 Herb
3D Molecular Structure
Myriocin (ISP-1)
Representative pattern: C₄H₂NO
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
